Suppr超能文献

单次使用环磷酰胺后的致命性肺毒性。

Fatal pulmonary toxicity after a single dose of cyclophosphamide.

作者信息

Gupta Shilpa, Mahipal Amit

机构信息

University of Connecticut Health Center, Farmington, Connecticut, USA.

出版信息

Pharmacotherapy. 2007 Apr;27(4):616-8. doi: 10.1592/phco.27.4.616.

Abstract

Cyclophosphamide is a chemotherapeutic agent with the potential to cause pulmonary toxicity, most commonly in the form of diffuse alveolar damage. Cyclophosphamide-induced pulmonary toxicity is extremely rare and often difficult to recognize because of presence of confounding factors, including use of other cytotoxic drugs, radiation pneumonitis, oxygen toxicity, pulmonary infections, and malignancies. The lung toxicity caused by cyclophosphamide is accelerated when cyclophosphamide is combined with amiodarone, an antiarrhythmic agent also capable of lung toxicity. We describe a patient with non-Hodgkin's lymphoma who developed fatal pulmonary toxicity after a single dose of cyclophosphamide in the setting of long-term amiodarone use.

摘要

环磷酰胺是一种化疗药物,有导致肺毒性的可能,最常见的形式是弥漫性肺泡损伤。环磷酰胺所致的肺毒性极为罕见,且由于存在混杂因素,包括使用其他细胞毒性药物、放射性肺炎、氧中毒、肺部感染和恶性肿瘤,往往难以识别。当环磷酰胺与胺碘酮(一种也可导致肺毒性的抗心律失常药物)合用时,环磷酰胺引起的肺毒性会加速。我们报告一例非霍奇金淋巴瘤患者,在长期使用胺碘酮的情况下,单次服用环磷酰胺后发生了致命的肺毒性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验